A Phase 2/3 interventional study of ACTH/Oral Steroids in West Syndrome, sponsored by All India Institute of Medical Sciences, New Delhi. Recruiting at 1 site in India. Open to participants aged 6 Months to 24 Months. Per ClinicalTrials.gov, last updated 2024-03-04.
Sponsored by All India Institute of Medical Sciences, New Delhi · Phase 2/3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Spasms, Infantile with a site in India — 2 open to participants now, 3 under way, 3 of them phase 3. Spasms, Infantile · India.
Among the 10 studies in Spasms, Infantile with a site in India, this one is the 7th largest by planned enrollment, is the only one that started in 2024, is one of 7 in phase 2/3, and was the 10th registered.
47 studies on the registry are indexed under Spasms, Infantile; 8 are open to participants now.
Browse Spasms, Infantile studies →2 of the 10 studies in Spasms, Infantile with a site in India are open now. Recruiting first, the newest first:
Lady Hardinge Medical College · Sites in India
Ages 9 mo–3 yrs
A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →
Of the 8 Spasms, Infantile studies recruiting now, none set no upper age limit and 8 stop at 75 or younger; 8 take children under 18; none take healthy volunteers.
This study: 6 Months to 24 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 7 · Phase 3 10
First in 2009; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is close to the median of 40 across 33 interventional studies indexed under Spasms, Infantile.
Median enrollment 63 across the 10 interventional studies. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 10 have an industry lead sponsor. The 4 most frequent:
All India Institute of Medical Sciences, New Delhi is the lead sponsor of 143 studies on the registry; 13 are open to participants now.
All India Institute of Medical Sciences, New Delhi has 3 studies filed under Spasms, Infantile — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Spasms, Infantile with a site in India, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Currently, no literature is available regarding degree of cortical excitability and its correlation with various epileptic syndromes and disorders such as West Syndrome in pediatric age group. Studying the complex interaction of cortical excitability, seizures, neurobehavioral patterns and brain maturation in children may provide valuable information and new insights about the underlying neuropathogenic pathways in childhood epilepsy. West Syndrome is a unique epilepsy syndrome amalgamating infantile onset epilepsy with significant neurodevelopmental delay. Due to this reason, it is the ideal disorder to study this complex interaction. How cortical excitability correlates with disease activity in West Syndrome is speculative. The ability of disease characteristics such as degree of cortical excitability to predict successful outcome after ACTH therapy (non-invasive biomarker of treatment response) in children with West Syndrome has not been explored.
Most importantly, the present study may be a hypothesis generating initial step bringing new insights into neurocognitive effects of seizures, seizure pathogenesis, individualized antiepileptic drug therapy and for studying treatment response.
The investigators aim to determine the change in cortical excitability pre and post ACTH therapy, in children with West syndrome and whether the change predicts responsiveness to ACTH therapy, in terms of reduction in spasm frequency at 12 weeks.
PATIENT ENROLLMENT AND MANAGEMENT:
ACTH therapy
KD therapy
TMS Intervention Protocol:
PARAMETERS METHODS Resting Motor Threshold (MT) - Single pulse TMS Site of stimulation - Motor Cortex Coil type- Circular coil MCF-125 (Coil outer diameter: 121 mm; Transducer head: 140.5 x 41.5 mm) Hemisphere - Bilateral hemisphere EMG recording - Contralateral APB muscle
Short interval cortical inhibition (SICI) - Paired pulse TMS in dominant hemisphere ISI - 3 msec Conditioning pulse - 80% of MT Test stimulus - 120% of MT
Long interval cortical inhibition (SICI) - Paired pulse TMS in dominant hemisphere ISI - 100 msec Conditioning pulse - 120% of MT Test stimulus - 120% of MT
Total Time Duration - 30 min The TMS will be given by machine make Magventure model no X100 with Magoption made in Denmark with standard circular coil as mentioned above.
Data Management and Analysis Data recording would be done in a Microsoft Excel spreadsheet (Microsoft Office, Microsoft Corp., Seattle, WA, USA).
Descriptive: Mean/Median/Range/Standard Deviation/Frequencies would be used to describe the demographic profile of participants and their comorbidities Comparative: A comparison between the two groups would be done. Categorical variables would be compared using Chi square/ Fischer's exact test. Depending upon the distribution of continuous variables -
Essentiality and Justification for the study: This study would be beneficial in generating a hypothesis as an initial step bringing new insights into seizure pathogenesis, planning individualized antiepileptic drug therapy and studying treatment response.
Consent: Patients will be enrolled only after obtaining informed written consent from the parents/guardians.
Privacy and confidentiality: Confidentiality of the records will be maintained. The parents/guardians will have full authority to enroll or withdraw the child from the study and this will not affect the future care and treatment given to the child in our hospital.
Costs of the investigations and therapy Investigations such as EEG and TMS whenever required will be done at no additional cost.
Immunotherapy which is the standard of care will be provided to the patient. All children included in the study would be examined in detail and the investigations and standard of care would be advised after they have fulfilled the inclusion criteria. Since, the investigators would be following the standard of care in every child, hence, every child enrolled would be benefitted.
The side effects and details of the investigations and intervention shall be explained to the parents in the language they understand the best and consent will be taken accordingly.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children, aged 6 months - 2 years with electroclinical diagnosis of West syndrome
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children receiving ACTH therapy for West Syndrome
Drug: ACTH/Oral Steroids
Drug pages: Adrenocorticotropic HormoneStudies of Adrenocorticotropic HormoneAdrenocorticotropic Hormone pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · SteroidsStudies of SteroidsSteroids pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Injection ACTH or Oral Steroids in children with West Syndrome
Also known as: Hormonal Therapy
Change in Cortical Excitability
Change in cortical excitability in terms of Transcranial magnetic stimulation parameters like Resting Motor Threshold, Long Interval Cortical Inhibition, Short Interval Cortical Inhibition
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Mar 2024; primary completion for May 2026, 26 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Adrenocorticotropic Hormone · Steroids
All India Institute of Medical Sciences, New Delhi →